Search Results - "Scholten, Marijke"
-
1
Autologous and Allogeneic Stem-Cell Transplantation for Transformed Chronic Lymphocytic Leukemia (Richter's Syndrome): A Retrospective Analysis From the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Published in Journal of clinical oncology (20-06-2012)“…Patients with Richter's syndrome (RS) have a poor prognosis with conventional chemotherapy. The aim of this study was to evaluate the outcome after autologous…”
Get full text
Journal Article -
2
Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation
Published in Haematologica (Roma) (01-05-2014)“…The clinical course of polycythemia vera and essential thrombocythemia is potentially associated with long-term severe complications, such as evolution to…”
Get full text
Journal Article -
3
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide
Published in Transfusion (Philadelphia, Pa.) (01-10-2014)“…Background Dimethyl sulfoxide (DMSO) is essential for the preservation of liquid nitrogen–frozen stem cells, but is associated with toxicity in the transplant…”
Get full text
Journal Article -
4
Should the standard dimethyl sulfoxide concentration be reduced? Results of a E uropean G roup for B lood and M arrow T ransplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide
Published in Transfusion (Philadelphia, Pa.) (01-10-2014)“…Background Dimethyl sulfoxide ( DMSO ) is essential for the preservation of liquid nitrogen–frozen stem cells, but is associated with toxicity in the…”
Get full text
Journal Article -
5
Prognostic Pre-Transplant Factors in Myelodysplastic Syndromes Primarily Treated by Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study on Behalf of the MDS Subcommittee of the Chronic Leukaemia Working Party of the EBMT
Published in Blood (18-11-2011)“…Abstract 3014▪FN2▪This icon denotes a clinically relevant abstract Allogeneic hematopoietic stem cell transplantation (SCT) is associated with iron overload…”
Get full text
Journal Article -
6
Allogeneic Stem Cell Transplantation for Patients with Chronic Myeloid Leukemia After Prior Treatment with Nilotinib or Dasatinib
Published in Blood (19-11-2010)“…Abstract 2348 Stem cell transplantation (SCT) will continue to be a treatment option for patients with chronic myeloid leukemia, despite the introduction of…”
Get full text
Journal Article -
7
DMSO Reduction Strategies Reduce DMSO Induced Post Autologous Transplant Morbidity In Patients with Lymphoma and Myeloma –Results from an EBMT Non Interventional Prospective Study
Published in Blood (19-11-2010)“…Abstract 2397 DMSO is the universally used cryoprotectant for freezing peripheral blood stem cell for autologous transplantation. DMSO has a significant side…”
Get full text
Journal Article -
8
Autologous and Allogeneic Stem Cell Transplantation for Richter's Transformation: A Retrospective Analysis From the Chronic Leukaemia Working Party and Lymphoma Working Party of the EBMT
Published in Blood (20-11-2009)“…Abstract 3360 Poster Board III-248 Richter's syndrome (RS) occurs in 2-8% of patients with chronic lymphocytic leukaemia (CLL). Clinical outcome has been…”
Get full text
Journal Article